Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.
Saved in:
| Title: | Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry. |
|---|---|
| Authors: | Barreiro‐de Acosta, Manuel1 (AUTHOR) manubarreiro@hotmail.com, Zabana, Yamile2 (AUTHOR), Nieto‐García, Laura1 (AUTHOR), Poncela, Marta3 (AUTHOR), Aguas, Mariam4 (AUTHOR), Martínez‐Cuevas, Cristina5 (AUTHOR), Argüelles‐Arias, Federico6 (AUTHOR), Calvo, Marta7 (AUTHOR), Gargallo‐Puyuelo, Carla J.8 (AUTHOR), Zabalza, Lucía9 (AUTHOR), Trastoy, Pilar Varela10 (AUTHOR), Boscá‐Watts, Maia M.11 (AUTHOR), Ceballos, Daniel12 (AUTHOR), Pascual, Cristina Martínez13 (AUTHOR), Rodríguez‐Moranta, Francisco14 (AUTHOR), de Castro Parga, María Luisa15 (AUTHOR), Suárez, Patricia16 (AUTHOR), Camps, Blau17 (AUTHOR), Royo, Vanesa18 (AUTHOR), Baston‐Rey, Iria1 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Jun2026, p1. 11p. 4 Illustrations. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
